Sign In
|
Register
|
About Mill Valley
|
Contact Us
Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast
|
Traffic
Mill Valley News
Local News
Bay Area News
Business
Technology
Real Estate
Sports
High School Sports
Mill Valley Gas Prices
Ski And Snow Reports
Financial Markets
Online Reservations
Acqua Hotel
Americas Best Value Inn And Suites Mill Valley
Holiday Inn Express Mill Valley San Francisco Area
Mill Valley Inn
Tamalpais Motel
Travelodge Mill Valley/Sausalito
Casa Madrona Hotel And Spa
Cavallo Point
The Gables Inn - Sausalito - Bed And Breakfast
Vacation Packages
Rental Cars
Flights
Mill Valley Hotels
Sausalito Hotels
San Rafael Hotels
San Francisco Hotels
Asian
Bagels
Bakery
Brazilian
Brew Pubs
Burgers
Chinese
Coffee Houses
Deli
Fast Food
Ice Cream / Frozen Yogurt
Italian
Mexican
Pizza
Sandwiches
Seafood
Sports Bars
Sushi
Tapas
Wine
Attractions
Muir Woods National Monument
Family Activities
Arts & Culture
Annual Events
Museums & Historical Places
Accommodations
Bed and Breakfast
Hotel and Motel Management
Hotels & Resorts
Vacation Rentals
Apartments
Apartment Finding & Rentals
Apartments
Senior Apartments
Art & Culture
Galleries & Dealers
Theatres
Associations, Foundations and Organizations
Business & Professional Clubs
Chambers of Commerce
Civic, Social and Fraternal
Labor Unions and Labor Organizations
Non-Profits
Professional & Trade Associations
Sales Organizations
Attractions & Entertainment
Activities
Air Tours
Biking
Comedy Clubs
Events & Festivals
Galleries
General Attractions
Golfing
Group Adventures
Horseback Riding
Movie Theatres
Parks & Preserves
Theatre
Tours
Automotive
Auto Detail
Auto Rental
Dealers - Antique & Classic
Dealers - New
Dealers - Used
Mobile Home Dealers
Motorcycles
Parts & Supplies
Repair & Service
Road Service
Tires
Towing
Window Tinting and Repair
Beauty & Fitness
Barbers
Beauty Salons
Cosmetics
Dance Clubs & Studios
Fitness Equipment & Apparel
Fitness Programs
Health Clubs & Gyms
Health Food Products & Vitamins
Health Services & Home Health
Manicures
Massage
Nutrition
Personal Trainers
Piercing & Tattoo
Plastic Surgeons
Skin Treatment
Weight Loss
Yoga
Bike, Hike, Team Building
Business & Professional Services
Appraisers
Benefit & Pensions Plans
Billing Services
Bookkeeping Service
Building Maintenance & Janitorial
Business & Labor Organizations
Business Legal Services
Chambers of Commerce
Communications Services
Computer & Audio Visual Services
Consultants
Copier & Fax Services, Equipment
Courier, Delivery & Messenger Service
Credit Check & Collection Agencies
Data Processing Service
Employment Services, Placement & Agencies
Engineer and Architect Services
Equipment & Supplies, Commercial & Industrial
Equipment Rentals
Graphic Design & Art
Human Resource Services
Industrial
Internet Services
Marketing & Advertising Services
Media Services
Notary Services
Office Furniture, Equipment & Supplies
Office Machines & Service
Office Supplies
Payroll Services
Photography
Printing & Publishing
Public Relations & Publicity
Screen Printing
Security & Investigative Services
Shipping, Packaging & Postal Services
Signs & Banners
Staffing & Support Services
Trade Shows, Expos & Conventions
Translators & Interpreters
Video Production
Contractors
Air Conditioning
Architects
Building Contractors & Consultants
Concrete
Electric
Fences and Gates
Floors & Ceilings
General Contractors
Heating, Cooling & AC
Inspectors & Surveyors
Landscaping
Painting & Wallcovering
Patio and Pool Enclosures
Plumbing
Pools, Spas & Saunas
Special Trade Contractors
Domestic Services
Child Care Services
House sitting
Housecleaning
Pet Sitting and Day Care
Education
Art Education
Colleges & Universities
Cont. Education
Elementary Schools
High Schools
Libraries
Middle Schools
Preschools & Childcare
Private & Parochial
Public
Tutoring
Employment Agencies
Financial Services
Accountants & Tax
Appraisers
Banks & Credit Unions
Bookkeeping
Check Cashing & Money Orders
Debt & Credit Counseling
Debt Help
Debt Services
Escrow Services
Financial Brokers and Dealers
Financial Consultants
Financial Planning and Services
Identity Theft Services
Investments
Loans
Mortgage Lenders
Personal
Golf
Government
City & County Government
National Government
Health and Medicine
Alternative Medicine / Acupuncture
Assisted Living & Elder Care Service
Chiropractors
Counseling
Dentistry
Eye Care
Health Care Professionals
Home Health Care
Hospitals & Clinics
Massage
Medical Doctors
Medical Equipment & Supplies
Nutrition
Physical Therapist
Physicians & Surgeons
Public Health & Safety
Social Services
Specialists - Health Care Professionals
Home & Garden
Accessories
Air Conditioning
Appliances
Building Materials & Hardware
Cabinets, Racks & Shelves
Carpets & Rugs
Cleaning Supplies & Services
Contractors
Doors, Windows & Drapery
Electric
Floor Coverings
Furniture
Garages
Glass
Handyman
Heating, Cooling & AC
Home Improvement Centers
Interior Design & Decorating
Kitchen
Lawn & Garden
Locksmiths
Lumber
Nurseries & Garden Centers
Painting & Wallcoverings
Patios & Decks
Plumbing
Pools, Spas & Saunas
Roofing & Siding
Safety & Security
Sewage & Septic Systems
Sprinklers
Tools
Insurance
Agents & Brokers
Auto
Health
Home
Life
Pets
Laser Hair Removal
Legal
Attorneys
Legal Services
Manufacturing & Industrial
Agriculture
Building Materials
Computers, Electronics & Telecommunications
Electronic Equipment
Food & Beverage
Home & Garden
Import / Export / Wholesale
Industrial Supplies & Services
Machine Shops
Plastics
Textiles & Apparel
Media
Online Publications
Print Publications
Meeting & Event Planning
Event Facilities
Meeting Planners
Party Rentals & Entertainment
Miscellaneous
Nightlife
Bars and Lounges
Dinner & Music Theatres
Events & Concerts
Live Music
Night Clubs
Outdoor Living & Spas
Personal Service
Barbers, Beauty Salons & Spas
Car Wash
Child Care
Dry Cleaning and Laundry
Shoe Repair
Tailors and Alterations
Tattoos & Body Piercing
Pets
Pet Boarding & Kennels
Pet Grooming
Pet Shops
Pet Supplies & Food - Retail
Veterinary Hospitals
Real Estate
Appraisers
Commercial
Condominiums
Developers
Mobile Home Parks
Mortgage Lenders
Property Management
Real Estate Agents and Brokers
Residential
Schools
Title Companies
Religion
Storage
Restaurants
American
Asian
Bagels
Bakery
Barbecue
Breakfast
Brew Pubs
Burgers
Chinese
Coffee Houses
Deli
Fast Food
French
Greek
Ice Cream / Frozen Yogurt
Indian
Italian
Japanese
Mexican
Pizza
Sandwiches
Seafood
Steaks, Chops
Sushi
Vegetarian
Wine Bar / Tasting Room
Shopping
Accessories
Antiques
Books
Bridal Shops
Candy Stores
Children's and Infants Clothing
Clothing
Convenience Stores
Department Stores
Electronics
Flowers
Furniture
Gas Stations
Gifts & Specialty Shops
Grocery Stores
Health Food Stores
Home Improvement
Indian Arts & Crafts - Retail
Jewelry
Men's Clothing Stores
Pharmacies
Resale Shops
Shoe Stores
Shopping Centers & Malls
Smoke Shops
Sporting Goods
Thrift Stores
Toy Stores
Videos
Women's Clothing Stores
Spas
Beauty Salons
Day Spas
Resort Spas
Sports & Recreation
Arenas and Venues
Associations & Clubs
Camping & Parks
Dance Clubs & Studios, Instruction
Docks & Marinas
Equestrian
Fitness Equipment & Apparel
Golf Courses
Hiking
Instruction
Recreation Facilities
Sporting Goods
Tennis
Technology
Communications
Computer Maintenance and Repair
Computer Services & Consultants
E-commerce
Internet Advertising & Services
Semiconductor
Software
Web Design
Web Development
Travel & Transportation
Airlines & Airports
Attractions
Auto Rentals
Bus Lines & Charters
Cruises
Hotels & Resorts
Passport Services
RV Parks and Recreational Vehicles
Taxi, Limousine & Shuttle
Tours & Excursions
Travel Agencies
Weddings
Cakes & Caterers
Ceremony & Reception Venues
Consultants & Planners
Entertainment
Florists
Your Business Here
Apartments
Real Eatate Agents
Mortgage Lenders
Relocating To Mill Valley
Classifieds
Jobs
Cars
Forums
Coupons
Archives
Contests
Search Hotels in Mill Valley
CHECK-IN:
CHECK-OUT:
ROOMS:
1
2
3
4
Find A Business
or
Browse Listings
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adaptimmune Ther ADR
(NQ:
ADAP
)
0.7998
+0.0742 (+10.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Adaptimmune Ther ADR
< Previous
1
2
Next >
Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024
October 31, 2024
Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - October 31, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining...
Via
Newsfile
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
September 20, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
September 16, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Adaptimmune to Participate in Two Bank Conferences this September
August 28, 2024
Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - August 28, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company working to...
Via
Newsfile
Adaptimmune Reports Q2 2024 Financial and Business Updates
August 12, 2024
Adaptimmune received U.S. FDA accelerated approval of Tecelra® (afami-cel), the first approved engineered cell therapy for a solid tumorPatients can...
Via
Newsfile
Exposures
Product Safety
Adaptimmune Receives U.S. FDA Accelerated Approval of TECELRA® (afamitresgene autoleucel), the First Approved Engineered Cell Therapy for a Solid Tumor
August 01, 2024
From
Adaptimmune Therapeutics plc
Via
Business Wire
Adaptimmune to Present Data from Planned Interim Analysis of Pivotal IGNYTE-ESO Trial with Lete-cel at ASCO; Data Continue to Support further Development of Sarcoma Franchise
June 03, 2024
Overall response rate of 40% consistent across sarcoma indications; median duration of response ~11 months with patients still in response...
Via
Newsfile
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Advancing US FDA Process, Featured Among Top Health Care Movers
May 31, 2024
Via
AB Newswire
Exposures
Product Safety
Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications
May 30, 2024
Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next-generation MAGE-A4 TCR T-cell...
Via
Newsfile
Adaptimmune Reports Q1 2024 Financial and Business Updates
May 15, 2024
Afami-cel commercial and regulatory update presented at Company's Investor Day (replay HERE); FDA review and inspections progressing with PDUFA date...
Via
Newsfile
Exposures
Product Safety
Adaptimmune Secures up to $125 Million Debt Financing with Hercules Capital
May 15, 2024
Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - May 15, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining...
Via
Newsfile
Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024
May 01, 2024
Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - May 1, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining...
Via
Newsfile
Strategic Collaboration between Adaptimmune and Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies Terminated
April 12, 2024
Company remains focused on launching afami-cel later this year with a PDUFA date of August 4th and developing its broader...
Via
Newsfile
Results of Adaptimmune's SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet
March 27, 2024
Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - March 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining...
Via
Newsfile
Adaptimmune Reports Q4/Full Year 2023 Financial Results and Business Updates
March 06, 2024
U.S. FDA accepted BLA for afami-cel for the treatment of advanced synovial sarcoma with priority review and a PDUFA date...
Via
Newsfile
Topics
Economy
Exposures
Product Safety
Supply Chain
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise
February 27, 2024
Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - February 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining...
Via
Newsfile
Adaptimmune to Report Q4 and Full Year 2023 Financial and Business Updates on Wednesday, March 6, 2024
February 21, 2024
Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - February 21, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining...
Via
Newsfile
Adaptimmune Announces U.S. FDA Acceptance of Biologics License Application for Afami-cel for the Treatment of Advanced Synovial Sarcoma with Priority Review
January 31, 2024
If approved, afami-cel will be the first engineered T-cell therapy for solid tumors and the first effective treatment option for...
Via
Newsfile
Exposures
Product Safety
Adaptimmune Projects Sarcoma Franchise to Deliver US Peak Year Sales up to $400 Million - Presentation at JP Morgan Healthcare Conference
January 04, 2024
Sarcoma franchise of afami-cel and lete-cel leverages same development and commercial footprint with US peak year sales projected to be...
Via
Newsfile
Exposures
Product Safety
Adaptimmune Completes Submission of Rolling Biologics License Application (BLA) to U.S. FDA for Afami-cel for the Treatment of Advanced Synovial Sarcoma
December 06, 2023
First BLA for an engineered T-cell therapy for solid tumors submitted to U.S. Food and Drug AdministrationAfami-cel data demonstrate better...
Via
Newsfile
Exposures
Product Safety
Adaptimmune Receives Transfer of IND for Lete-cel Program
November 29, 2023
Interim analysis of pivotal IGNYTE-ESO trial demonstrates 40% response rate in people with synovial sarcoma or myxoid/ round cell liposarcoma...
Via
Newsfile
Adaptimmune Reports Third Quarter Financial Results and Business Update
November 08, 2023
Afami-cel: overall survival for people with synovial sarcoma who received afami-cel is superior to historic controls (CTOS 2023); BLA submission...
Via
Newsfile
Adaptimmune Selects ADP-600 as Clinical Candidate for Best-in Class PRAME Strategy
November 08, 2023
Candidate is 10x more sensitive to target peptide than competitor candidatesEntry into the clinic in 2024Selection of approaches from next-gen...
Via
Newsfile
Adaptimmune Reports Better Outcomes for People with Synovial Sarcoma who Received Afami-cel Compared to Historical Control
October 31, 2023
~39% of patients who received afami-cel in the pivotal SPEARHEAD-1 trial had clinical responses with a median duration of response...
Via
Newsfile
Adaptimmune Reports Positive Data with Lete-cel[1] from an Interim Analysis of the Pivotal IGNYTE-ESO Trial for People with Synovial Sarcoma or MRCLS
October 31, 2023
40% (18/45) of people with synovial sarcoma or MRCLS and who have received ≥ 2 prior lines of therapy had...
Via
Newsfile
Adaptimmune to Report Q3 2023 Financial and Business Updates on Wednesday, November 8, 2023
October 25, 2023
Philadelphia, Pennsylvania and Oxfordshire, United Kingdom--(Newsfile Corp. - October 25, 2023) - Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in...
Via
Newsfile
Next-Generation TCR T-cell Therapy (ADP-A2M4CD8) Demonstrates Strong Efficacy in a Broad Range of Solid Tumors; Adaptimmune Presents Data Update from its SURPASS trial at ESMO
October 23, 2023
35% response rate in the ADP-A2M4CD8 monotherapy cohort with ~5 months median duration of response in heavily pre-treated patients across...
Via
Newsfile
Dr. Karen Chagin Joins Adaptimmune as Senior Vice President of Early-Stage Development
September 11, 2023
Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - September 11, 2023) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a leader in cell therapy to treat cancer, today announces...
Via
Newsfile
Adaptimmune Reports Second Quarter Financial Results and Business Update
August 09, 2023
Substantial progress on the afami-cel BLA including FDA agreement on plan for confirmatory evidence and favorable feedback on commercial T-cell...
Via
Newsfile
Exposures
Product Safety
Adaptimmune to Report Q2 2023 Financial and Business Updates on Wednesday, August 9, 2023
August 03, 2023
Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - August 3, 2023) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a leader...
Via
Newsfile
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
About Us
|
Contact Us
|
Privacy Policy
|
User Agreement
|
Advertise With Us
|
Site Map
Home
|
News
|
Travel
|
Restaurants
|
Nightlife
|
Things To Do
|
Shopping
|
Calendar
|
Directory
|
Real Estate
|
Blog
|
More
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.